| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |